Feeds
Federal health experts said Wednesday an updated version of Pfizer's best-selling anti-infection vaccine is safe and effective for infants and toddlers, despite company studies that failed to meet certain goals.
Google, Yahoo and other Web companies joined the pharmaceutical industry Thursday in urging federal regulators to make it easier to pitch drugs in online advertisements.
As federal regulators take their first tentative steps toward policing the wild west of medical information online, pharmaceutical companies are pressing their case to market drugs via Google, Twitter and other Web sites.
Last year pharmaceutical companies spent more than $4 billion urging patients like you to "ask your doctor" about their drugs. But if you want a prescription that won't empty your wallet, while still keeping you well, you might start asking your doctor about drugs you don't see on TV.
Federal health officials say an implant from Zimmer Holdings Inc. appears to be effective in treating spinal problems, but questions remain about whether company payments to doctors influenced the device's trial data.
Medicare officials are backing off a policy that pushed many doctors to use a $2,000 injectable drug for a potentially blinding eye disorder, over a similar treatment that costs about $50.
The Food and Drug Administration has allowed drugs for cancer and other diseases to stay on the market even when follow-up studies showed they didn't extend patients' lives, say congressional investigators.
Democratic lawmakers are seeking to stir up competition by stripping health insurers of their protection from certain federal antitrust laws, although experts shrug off the effort as largely symbolic.
Did you know that Lunesta will help you fall asleep just 15 minutes faster? Or that a higher dose of the osteoporosis drug Zometa could damage a cancer patient's kidneys and raise their risk of death?
Shares of Acorda Therapeutics plummeted Friday after the Food and Drug Administration issued a negative opinion that questioned the safety and effectiveness of the company's multiple sclerosis drug.
"Just spit." With those simple instructions, health care providers in California are hoping to expand the use of genetic testing to make sure patients get the right medication.
The Food and Drug Administration has taken the unprecedented step of acknowledging that it buckled to "extreme" pressure from Capitol Hill in its approval of a knee repair device last year. While FDA officials call the situation an anomaly, experts said Friday there is nothing to stop similar political lobbying from influencing future decisions.
The Food and Drug Administration failed to follow its own rules when it approved a knee repair product last year against the recommendation of its own scientists, according to an internal probe.
Abbott Laboratories says results of a large study place its artery-opening Xience stent on equal footing with competitor Boston Scientific in diabetics, a difficult-to-treat group of patients.
U.S. health regulators have warned drugmaker Bayer over quality control issues at a plant that makes the key ingredient in Yaz and other popular birth control drugs.
British drugmaker GlaxoSmithKline is scrambling to shore up the safety image of its weight loss pill alli, after watching sales dive on news that federal regulators are investigating the drug.
Drug and medical supplies distributor Cardinal Health will spin off its medical device division this week, streamlining operations after more than a decade of diversified growth, a strategy which analysts say never quite panned out.
A government watchdog will tell Congress Wednesday that the pharmaceutical and medical device industries' billion-dollar spending spree for medical education is threatening the judgment of physicians across the country.
Biotech drugmaker Human Genome Sciences reported positive results Monday for its experimental lupus drug, confounding analyst expectations and potentially clearing the way for the first new treatment against the inflammatory disease in a half century.
The Food and Drug Administration — which has struggled to fulfill its mission of regulating food, drugs and other consumer goods that make up nearly a quarter of the U.S. economy — does not have the expertise to forecast its own budget needs, according to congressional investigators.
Medtronic Inc., the world's largest medical device maker, paid Chief Executive Bill Hawkins $8.9 million in total compensation for fiscal 2009, a 26 percent increase, according to an analysis by the Associated Press.
Government experts are scheduled to vote Tuesday on a range of options to curb deadly overdoses with Tylenol and other pain relievers, including reducing dosages and even pulling certain products off the market.
Complaints about a contact lens solution linked to a 2007 outbreak of eye infections that blinded several people went unreported by the manufacturer for more than a year, government documents show.
The biotechnology industry's demand for up to 14 years of competition-free marketing before cheaper copies of their drugs can be launched is unnecessary and would discourage development of new treatments, the Federal Trade Commission told lawmakers Thursday.
Advisers to the Food and Drug Administration are scheduled to vote Wednesday on whether three powerful psychiatric drugs should be approved for children, despite side effects that can increase the risk of diabetes.
Log In | Register
